Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19Original paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined whether gut microbiome composition is linked to disease severity in patients with COVID-19, and whether any microbiome disturbances resolve after the SARS-CoV-2 virus is cleared. Researchers used shotgun sequencing of total DNA extracted from stool samples to characterize gut microbiome composition. They also measured concentrations of inflammatory cytokines and other blood markers from plasma to relate gut microbial changes to immune dysfunction.
Who was studied?
The study drew on a two-hospital cohort of 100 patients with laboratory-confirmed SARS-CoV-2 infection, from whom blood, stool, and patient records were collected. Serial stool samples were collected from 27 of these 100 patients for up to 30 days after clearance of the virus, allowing the researchers to track whether microbiome changes persisted or resolved over time.
What were the most important findings?
Gut microbiome composition was significantly altered in patients with COVID-19 compared with non-COVID-19 individuals, regardless of whether patients had received medication. Several gut commensals with known immunomodulatory potential, including Faecalibacterium prausnitzii, Eubacterium rectale, and bifidobacteria, were underrepresented in patients with COVID-19. These organisms remained depleted in stool samples collected up to 30 days after disease resolution, indicating the perturbation did not quickly correct itself.
What are the greatest implications of this study?
The persistence of a disturbed gut microbiome for weeks after viral clearance suggests COVID-19 related gut dysbiosis is not merely a transient bystander effect of infection. Because the depleted organisms, including Faecalibacterium prausnitzii, are known for anti-inflammatory and immunomodulatory functions, their loss may contribute to dysfunctional immune responses seen in the disease. This points to the gut microbiome as a potential factor in COVID-19 severity and recovery, meriting further investigation as a target for monitoring or intervention.